Where energy meets experience

Navigate the complex pathway to patients with ease

Three professionals discussing pharmaceutical market access consultancy strategy in a meeting setting.

Who we are

We are a team of bold, dynamic thinkers with deep expertise in pharmaceutical market access, regulatory affairs, medical and scientific strategy, and public policy. Rooted in local expertise and driven by global collaboration, we empower health technology developers to deliver impactful therapies to patients across Europe.

Our approach combines agility with precision, guiding you through the complexities of European patient access with confidence and clarity.

Explore your journey

Phase 1 for Pharmaceutical Market Access Consultancy Icon

01

Phase I

Build confidence with compliant, scalable early regulatory and clinical trial strategies.

Phase 2 and 3 for Pharmaceutical Market Access Consultancy Icon

02

Phase II-III

Generate evidence that aligns with payer needs and drives impact.

Registration for Pharmaceutical Market Access Consultancy Icon

03

Registration

Achieve first-time regulatory and HTA approval with aligned submissions and proactive planning.

Post-Launch for Pharmaceutical Market Access Consultancy Icon

04

Post-launch

Sustain long-term market access and impact with strategic post-launch support.

EPRI - EndPoint Result Interpreter

EPRI (EndPoint Result Interpreter) is a cutting-edge, user-friendly AI solution designed to streamline the creation of tailored, high-quality German AMNOG, UK NICE and EU Joint Clinical Assessment (JCA) dossiers. Our innovative technology helps to manage complexity, reduce time and costs and ensure the highest standards of accuracy and reliability.

Our expertise:

Strategic Advisory

We are your partner in overcoming the complexities of European markets, offering customised solutions to guide you seamlessly through every step of the patient access journey from development and registration through access and launch preparedness.

National Market Access Strategy & Negotiation

Your path to success begins with a clear, well-defined strategy. At Kintiga, we combine local insights with therapeutic expertise to unlock Europe’s healthcare markets.

EU HTA

Our European team expertly navigates the complexities of EU HTA procedures, providing both strategic guidance & comprehensive end-to-end support for JSCs & JCAs at every stage of the process. We are committed to ensuring your products reach patients across Europe efficiently & effectively.

Pricing Strategy

Our experts start with what matters most to access stakeholders and work backwards to develop robust pricing and reimbursement strategies tailored to each market to reflect the value for your product.

Value Communication & Stakeholder Management

We transform complex evidence into compelling, compliant narratives. Through evidence-based storytelling and stakeholder input, we help your product achieve its full potential across diverse markets.

HEOR & Modelling

At Kintiga our expertise in modelling data, outcomes, and costs provides stakeholders with clarity to fully understand the value of treatments, which is vital for healthcare decision making.

Our products

Navigate evolving regulations and market demands confidently with up-to-date insights and guidance from Kintiga’s innovative AI-powered digital tools.

Hive by Kintiga

Access the collective expertise of our consultants and the insights and strategic guidance to simplify approvals across Europe’s healthcare any time and from anywhere.

EPRI

EPRI (EndPoint Result Interpreter) is a cutting-edge AI solution designed to streamline the creation of tailored, high-quality  dossiers.

Our experience

Get in touch

Contact us to discover how we can support your journey towards pharmaceutical market access & patient access.

Sign up for the Kintiga Newsletter

Stay connected by registering to receive the latest insights from Kintiga, delivered straight to your inbox.

Scroll to Top